UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013665
Receipt number R000015946
Scientific Title A quasi-randomized clinical trial of oral tramadol versus low dose oxycodone for initial control of moderate cancer-related pain.
Date of disclosure of the study information 2014/04/08
Last modified on 2015/04/12 09:16:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A quasi-randomized clinical trial of oral tramadol versus low dose oxycodone for initial control of moderate cancer-related pain.

Acronym

A comparison of tramadol and oxycodone for cancer pain.

Scientific Title

A quasi-randomized clinical trial of oral tramadol versus low dose oxycodone for initial control of moderate cancer-related pain.

Scientific Title:Acronym

A comparison of tramadol and oxycodone for cancer pain.

Region

Japan


Condition

Condition

Malignant neoplasm

Classification by specialty

Not applicable

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This prospective study aims to investigate the safety and efficacy of tramadol and low dose oxycodone for moderate cancer pain.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

Analgesic effects (NRS, STAS-J)
Adverse effect rate

Key secondary outcomes

Efficacy rate


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Oral tramadol (100 - 300 mg/day) was given until the initial signs of significant analgesia were detected by patients

Interventions/Control_2

Low dose oxycodone (10 - 40 mg/day) was given until the initial signs of significant analgesia were detected by patients

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with moderate cancer-related pain (NRS 3 - 8 and STAS-J 2 - 3).
Patients who agreed to participate in the study and signed informed consent form.

Key exclusion criteria

Patients with previously receiving opioid adminittration.
Patients with severe cancer-related pain (NRS 9 - 10 and/or STAS-J 4).

Target sample size

36


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toru Kajiyama

Organization

Kansai Electric Power Hospital

Division name

Department of Palliative Medicine

Zip code


Address

2-1-7, Fukushima, Fukushima-ku, Osaka City, Osaka, 553-0003 Japan

TEL

06-6458-5821

Email

mtkaji@live.jp


Public contact

Name of contact person

1st name
Middle name
Last name Motonao Kurahashi

Organization

Kansai Electric Power Hospital

Division name

Department of Pharmacy

Zip code


Address

2-1-7, Fukushima, Fukushima-ku, Osaka City, Osaka, 553-0003 Japan

TEL

06-6458-5821

Homepage URL


Email

kurahashi.motonao@c3.kepco.co.jp


Sponsor or person

Institute

Kansai Electric Power Hospital

Institute

Department

Personal name



Funding Source

Organization

Kansai Electric Power Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

関西電力病院(大阪府)


Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 08 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://www.jsphcs.jp/gakkaishi/kaishi/40-11.php

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 02 Month 14 Day

Date of IRB


Anticipated trial start date

2011 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 04 Month 08 Day

Last modified on

2015 Year 04 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015946


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name